-
my country has 22 new crown vaccines in clinical trials
Time of Update: 2021-07-29
Yuan Lin, Director of the Department of Drug Supervision and Administration of the State Drug Administration, introduced at the State Council’s policy briefing on the 8th that the State Drug Administration has approved 22 new crown vaccines with 5 technical routes to enter clinical trials, and have conditions attached in accordance with laws and regulations.
-
Experts worry about death of Belgian female infected with dual mutant strain
Time of Update: 2021-07-29
" Wan Kebogen said that it is currently difficult to determine whether the infection of the two variants of the virus is related to the rapid deterioration of the patient's condition .
-
The mannitol registration number is activated, and the preparations such as montelukast sodium granules and risperidone orally disintegrating tablets can be seen
Time of Update: 2021-07-29
It is suitable for powder direct compression and dry granulation processes, and is commonly used in swallowing tablets, chewable tablets, orally disintegrating powders, effervescent tablets, lozenges and hard capsules .
XL Opal has high compressibility, high drug loading, fast disintegration, low friability and good taste .
-
Notice on Public Solicitation of ICH Guiding Principles "S1B(R1): Drug Carcinogenicity Test: S1B Supplementary Document"
Time of Update: 2021-07-29
The ICH guiding principle "S1B(R1): Drug Carcinogenicity Test: S1B Supplementary Document" is now in the third stage for comments .
We now solicit public opinions on the guiding principles and the Chinese translation .
-
Health Commission: 28 new confirmed cases and 5 local cases are in Yunnan
Time of Update: 2021-07-29
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 14 The latest situation of the novel coronavirus pneumonia as of 24:00 on July 14 The latest sit
-
With a sales volume of US$1.86 billion in 2020, Roche enmetrastuzumab will soon be approved for new indications in China
Time of Update: 2021-07-29
As the first single-agent ADC approved for the treatment of HER2-positive metastatic breast cancer that has previously received trastuzumab and taxane chemotherapy (alone or in combination), Kadcyla's sales have increased year by year after its launch, reaching 1.
-
Xin Yuling, a pioneer of thoracic surgery in New China: a hundred-year-old doctor with benevolence and kindness
Time of Update: 2021-07-29
He is Xin Yuling, the Sino-Japanese Friendship Hospital's first president , the cause of thoracic surgery pioneer and founder of New China .
Not long ago, the Xin Yuling Team of the China-Japan Friendship Hospital was formally established .
-
Hengrui Medicine Carrelizumab: First PD-1 approved for first-line nasopharyngeal carcinoma indication
Time of Update: 2021-07-29
Recently, independent research and development by the Hengrui Medicine PD-1 inhibitors Ka Ruili natalizumab (Erica ® ) was "Drug Registration Certificate" State Drug Administration (NMPA) approval issued by the approval of a single bead Ka Ruili Anti-combined cisplatin and gemcitabine are used for the first-line treatment of patients with locally recurring or metastatic nasopharyngeal carcinoma .
-
CXO listing feast: after 4 arrows in a row, there are 7 more on the road
Time of Update: 2021-07-29
Basic situation of the four newly listed CXO companies Data source: prospectus Unit: 100 million yuan PE static (calculated based on 2020 net profit) Market value is based on the closing price at noon on June 28 From the above table, it has the following characteristics: 0 1 From the perspective of PE and market value, the capital market gives new high valuations .
-
Health Commission: 18 new cases on the 28th, all imported from abroad
Time of Update: 2021-07-29
As of 24:00 on June 28, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 459 confirmed cases (including 12 severe cases), 86,676 cured and discharged cases, and 4,636 deaths.
-
Key mutations may cause cross-species transmission of new coronavirus
Time of Update: 2021-07-29
Liu Xia In the latest study, scientists from Virginia Tech analyzed 182,000 new coronavirus genomes to explore mutations that may help the virus adapt to and spread among humans .
-
Legendary curtain call!
Time of Update: 2021-07-29
Although as an enterprise with annual sales of nearly 100 billion yuan, Yangtze River Pharmaceutical has not yet been listed.
Xu Jingren also revealed that Yangtze River Pharmaceutical will also invest more than 4 billion yuan in Chinese medicine.
-
WHO: There may be a more dangerous and difficult to control variant of the new crown virus
Time of Update: 2021-07-29
WHO: A more dangerous and more difficult-to-control variant of the new coronavirus may appear BEIJING, July 16 (Xinhua) reported, the WHO emergency committee will be the 15th issued a statement saying, "The new crown pandemic have not seen the end .
-
The "patent cliff" crisis of the world's top four best-selling drugs is approaching. How do AbbVie, Merck and BMS respond?
Time of Update: 2021-07-29
In fact, AbbVie has also made preparations for many years to deal with Humira's "patent cliff", successfully preventing the listing of biosimilar drugs in the United States through patent strategies, negotiations, and litigation .
-
Interleukin-6 receptor antagonist included in the new crown treatment plan
Time of Update: 2021-07-29
This is a class of drugs that have a life-saving effect on critically ill patients with new coronary disease, especially when used in combination with corticosteroids .
-
Gaofu team's new Zika vaccine "kills two birds with one stone"!
Time of Update: 2021-07-29
" Dai Lianpan said, given the potential long-term effects of Zika virus infection on newborns by pregnant women With serious consequences, it is particularly important to develop a Zika vaccine that can induce a clear immune response in mothers and infants .
-
WHO releases guidelines for cervical cancer screening, first HPV-DNA test
Time of Update: 2021-07-29
The World Health Organization and the United Nations Special Programme for Human Reproduction jointly issued a new guide on the 6th to help countries better carry out cervical cancer screening and treatment, which recommends HPV-DNA (human papillomavirus-deoxyribonucleic acid) testing As the preferred screening method for cervical cancer screening .
-
These 17 varieties encourage imitation!
Time of Update: 2021-07-29
On March 15, the official website of the National Health Commission issued the "Notice on Printing and Distributing the Second Batch of Catalogues of Encouraging Generic Drugs .
The second batch of catalogues of encouraged generic drugs Source: National Health Commission official website
-
Popular science: why some people are born immune to the new coronavirus
Time of Update: 2021-07-29
" The summary is as follows: A new study by MedGenome, a genomic data provider, analyzes why some people who are not infected with the new coronavirus and have not been vaccinated are immune to the disease, or at least avoid serious symptoms .
-
Approved 29 new drugs in the first half of the year
Time of Update: 2021-07-29
0 1 Aduhelm (Bojian): The first AD drug to improve disease progression0 2 Breyanzi, Abecma (BMS): CAR-T adds two more members but the competition is fierce0 3 Brexafemme (Synexis): The first new antif